← Leaderboards
Yuanpei Li
Lamnotherapeutics, Inc.
$13,283,377
Attributed
$14,879,414
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2014–25$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,879,414 · 9
By mechanism
R01$14,460,602 · 7
R43$225,000 · 1
U43$193,812 · 1
Top collaborators
- Yoshihiro Izumiya6 shared
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsToxic EffectPharmaceutical PreparationsSiteDrug Delivery SystemsIn VivoNanoparticleMagnetic Resonance ImagingTissuesTumor MicroenvironmentPublishingOptical ImagingSeriesPenetrationResponseMolecularLigandsDrug KineticsBiodistributionBlood CirculationInnovationEncapsulatedXenograft Model
Grant awards (33)
Development of novel nanotherapeutics to overcome therapy resistance using canine brain tumor as a spontaneous model$634,743
R01 · FY2025 · CA · contact PI
A âSTICKâ theranostic nanoplatform for image-guided drug delivery to brain malignancies$615,825
R01 · FY2025 · EB · contact PI
Two-way Magnetic Resonance Tuning Nanoprobe Enhanced Subtraction Imaging for Precision Diagnosis of Brain Metastasis$599,174
R01 · FY2025 · EB · contact PI
Two-way Magnetic Resonance Tuning Nanoprobe Enhanced Subtraction Imaging for Precision Diagnosis of Brain Metastasis$92,549
R01 · FY2025 · EB · contact PI
Development of novel nanotherapeutics to overcome therapy resistance using canine brain tumor as a spontaneous model$634,743
R01 · FY2024 · CA · contact PI
A âSTICKâ theranostic nanoplatform for image-guided drug delivery to brain malignancies$603,509
R01 · FY2024 · EB · contact PI
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer$590,685
R01 · FY2024 · DE · contact PI
Two-way Magnetic Resonance Tuning Nanoprobe Enhanced Subtraction Imaging for Precision Diagnosis of Brain Metastasis$589,688
R01 · FY2024 · EB · contact PI
Two-way Magnetic Resonance Tuning Nanoprobe Enhanced Subtraction Imaging for Precision Diagnosis of Brain Metastasis$24,866
R01 · FY2024 · EB · contact PI
A âSTICKâ theranostic nanoplatform for image-guided drug delivery to brain malignancies$611,998
R01 · FY2023 · EB · contact PI
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer$602,740
R01 · FY2023 · DE · contact PI
A âSTICKâ theranostic nanoplatform for image-guided drug delivery to brain malignancies$610,088
R01 · FY2022 · EB · contact PI
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer$603,179
R01 · FY2022 · DE · contact PI
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$537,395
R01 · FY2022 · CA
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer$578,900
R01 · FY2021 · DE · contact PI
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$537,395
R01 · FY2021 · CA
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$743,574
R01 · FY2020 · CA
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer$525,840
R01 · FY2020 · DE · contact PI
Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors$293,197
R01 · FY2020 · HD · contact PI
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$537,395
R01 · FY2019 · CA
Stimuli-responsive crosslinked theranostics against advanced prostate cancer$348,363
R01 · FY2019 · CA · contact PI
Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors$325,775
R01 · FY2019 · HD · contact PI
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$206,179
R01 · FY2019 · CA
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$630,136
R01 · FY2018 · CA
Stimuli-responsive crosslinked theranostics against advanced prostate cancer$359,138
R01 · FY2018 · CA · contact PI
Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors$325,775
R01 · FY2018 · HD · contact PI
Stimuli-responsive crosslinked theranostics against advanced prostate cancer$359,138
R01 · FY2017 · CA · contact PI
Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors$325,775
R01 · FY2017 · HD · contact PI
Stimuli-responsive crosslinked theranostics against advanced prostate cancer$359,138
R01 · FY2016 · CA · contact PI
Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors$311,049
R01 · FY2016 · HD · contact PI
Stimuli-responsive crosslinked theranostics against advanced prostate cancer$342,653
R01 · FY2015 · CA · contact PI
On-demand releasing nano-VCR for effective neuroblastoma therapy$225,000
R43 · FY2015 · HD · contact PI
Smart targeting nano-doxorubicin against breast cancer$193,812
U43 · FY2014 · CA · contact PI